Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025)
Precision Biosciences (DTIL) reported Liabilities from Discontinued Operations of 885000.0 for Q3 2025, down 32.13% year-over-year from 1304000.0 in Q3 2024, and little changed quarter-over-quarter from 885000.0 in Q2 2025.
Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends
Precision Biosciences (DTIL) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 885000.0 in Q3 2025.
- Liabilities from Discontinued Operations for Q3 2025 came in at 885000.0, down 32.13% year-over-year; the trailing twelve-month figure through Sep 2025 was 885000.0 (down 32.13% YoY), and the FY2024 annual result was 1204000.0, down 52.09% from the prior year.
- Liabilities from Discontinued Operations was little changed at 885000.0 in Q3 2025 per DTIL's latest filing, from 885000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 3465000.0 in Q4 2022 and troughed at 885000.0 in Q1 2025.
- A 4-year average of 1559200.0 and a median of 1304000.0 in 2024 frame the typical range for Liabilities from Discontinued Operations.
- On a YoY basis, Liabilities from Discontinued Operations climbed as much as 20.54% in 2024 and fell as far as 52.09% in 2024.
- A 4-year view of Liabilities from Discontinued Operations shows it stood at 3465000.0 in 2022, then decreased by 27.47% to 2513000.0 in 2023, then sank by 52.09% to 1204000.0 in 2024, then slipped by 26.5% to 885000.0 in 2025.
- Business Quant data shows DTIL's Liabilities from Discontinued Operations at 885000.0 in Q3 2025, 885000.0 in Q2 2025, and 885000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 885,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 885,000.00 |
| Mar 31, 2025 | 885,000.00 |
| Mar 31, 2025 | 885,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 2.51 Mn |
| Dec 31, 2023 | 2.51 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Dec 31, 2022 | 3.47 Mn |